Thus, this study aims to further investigate the association between kisspeptin, neurokinin B (NKB) and dynorphin and other endocrine and metabolic variables with the LH/FSH ratio in lean PCOS patients. This evidence concerns the gene BRD2 and polycystic ovary syndrome.